CSF Aβ42and tau in Parkinson's disease with cognitive impairment-Reference-Cited by-同舟云学术

CSF Aβ42and tau in Parkinson's disease with cognitive impairment

Published:2010-09-03 Issue:15 Volume:25 Page:2682-2685
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Montine Thomas J.,Shi Min,Quinn Joseph F.,Peskind Elaine R.,Craft Suzanne,Ginghina Carmen,Chung Kathryn A.,Kim Hojoong,Galasko Douglas R.,Jankovic Joseph,Zabetian Cyrus P.,Leverenz James B.,Zhang Jing

Funder

NIH

Michael J. Fox Foundation

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference19 articles.

1. Mild cognitive impairment as a diagnostic entity;Petersen;J Intern Med,2004

2. Biomarkers for cognitive impairment and dementia in elderly people;Sonnen;Lancet Neurol,2008

3. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects;Shaw;Ann Neurol,2009

4. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment;Mattsson;JAMA,2009

5. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study;Li;Neurology,2007

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease;Journal of Neurology;2024-09-09

2. In Parkinson’s disease, affective and chronic fatigue syndrome symptoms are associated with neuronal damage markers;2024-05-21

3. Parkinson’s disease with anxiety: clinical characteristics and their correlation with oxidative stress, inflammation, and pathological proteins;BMC Geriatrics;2024-05-16

4. Cerebrospinal fluid protein biomarkers in Parkinson's disease;Clinica Chimica Acta;2024-03

5. Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease;International Journal of Molecular Sciences;2024-01-30